Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Revlimid (Celgene)

Showing 1-1 of about 1 articles.

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Files an IND with the FDA to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center

EAST SETAUKET, NY , Oct. 09, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that it has submitted an IND to the FDA to conduct a Phase 1b/2 trial of the safety...

October 09, 2018

Showing 1-1 of about 1 articles.

Lixte Biotechnology Files an IND with the FDA to Conduct a Phase 1b/2 Trial of LB-100 in Patients with Myelodysplastic Syndrome at Moffitt Cancer Center

Newswire Distribution Network & Management

About Us